(7 years, 1 month ago)
Commons ChamberI come back to the point I made earlier. We seem to see these themes. Rather than having multiple separate inquiries, should we consider issues such as Primodos and valproate together? Common learnings need to come out of them.
I absolutely agree. I hope to pull that issue together as I go on with my remarks. It is really important that we raise the case of sodium valproate, which, as we have heard, is still in use. All of these issues need to be looked at.
Common to this debate—and in all such cases, including Primodos—are the hidden, missing and lost documents, along with a delay in education and information. That was raised again today by the right hon. Member for North Norfolk. I pay tribute to Sky News for its exposés on valproate and Primodos, because this really matters to the families affected.
(7 years, 4 months ago)
Commons ChamberI congratulate the hon. Member for Kingston upon Hull North (Diana Johnson) on securing this important debate. I was in the Chamber when the former Member for Leigh raised these very concerning issues, which need to be looked at in the inquiry. That struck a chord with me, so I am delighted to be back in the Chamber to see this debate.
Like many Members on both sides of the House, I have been contacted by constituents who have told me about their experiences and about how contaminated blood has affected them, their family life and their friends. Every so often as a constituency MP, we meet the saddest constituents who tell us the most heartbreaking stories. We sit there week in, week out, and those stories resonate with us, but they are not stories for the victims—they are daily life. These are wrecked lives, but the people have done nothing wrong of their own accord—it is pure injustice.
It is clear that the contaminated blood products that were used decades ago have continued daily to affect people’s lives in a devastating and destructive way. When I have heard the stories of how people have been affected, they have lived with me, and I can understand the campaigning that has been done by Members on both sides of the House. I am therefore delighted to talk about my constituents’ experiences.
Today, we finally recognise what has happened, and the Government are ready to tackle this injustice. I am delighted that that is being done in the name of the victims and their families, who did nothing to bring this on themselves.
After I became the MP for Eastleigh in May 2015, I met one of my constituents from Bishopstoke, Gary Webster, who has been left coping with HIV, hepatitis C and possibly variant Creutzfeldt-Jakob disease as a result of the NHS blood products that were used during a routine procedure in the 1980s to treat his haemophilia.
It will be important that the inquiry goes far enough back. The decision to heat-treat albumin for hepatitis B was made in the mid-60s, but we did not treat concentrates. We need to make sure that all these conditions are included.
I thank the hon. Lady for that input. It is absolutely right that she, like all our constituents, brings her experience to this. We need to make sure that we do go back far enough.
Last year, Gary attended a debate we had here once again to discuss this heartbreaking issue. He attended a specialist school in Alton, where he was one of many haemophiliacs. He told me that he kept in contact with around 100 other students, all of whom had been affected by contaminated blood, although only around 20 were still alive. These students all contracted illnesses through blood products they had received because of their haemophilia. Tragically, Gary’s story is similar to that of thousands of others across the country.
Other constituents, some of whom wish not to be named, have had grave financial burdens placed on them and their families as a result of the diseases they contracted from contaminated blood, which have affected their lives. It is only right that we support those whose lives have been significantly affected by these contaminated products. I am therefore pleased to hear about the additional support that the Government will provide to those who have been roundly affected. I am particularly pleased that the annual payments for those with hepatitis stage 2 will increase to £15,500, and then to £18,500 in 2018-19. Payments to those co-infected with HIV and hepatitis stage 2 will also go up, to £36,500 by 2018-19. I am pleased to see that these payments will be linked to CPI.
That will help to support all our constituents we know have been affected. I know from speaking to Gary and others about the real hardship and challenges these conditions have brought to their lives, and about the difficulty they face in working, and in bringing up and supporting their families in the way they would have liked had they not been affected.
Almost £400 million has been paid out to those affected by five different organisations, which have been funded by the Department of Health. I am delighted to hear about the £125 million the Government have committed as additional funding for the reformed scheme, which will double the Department’s annual spend on the scheme over the next five years. That money must go to the people who really need it—that should absolutely be noted—because the daily-life decisions they have made have been really difficult because of their financial impact.